Ionis Pharmaceuticals
Filed with the SEC on · accession 0000874015-26-000271
IONS filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -21.4% by the first close after the filing.
Ionis Pharmaceuticals filed its quarterly 10-Q report for the period ended September 30, 2026, reporting cash and short-term investments of approximately $1.88 billion and total assets of $2.91 billion.
Close before
$39.42
Nov 6, 2026
First close after
-21.36%
$31.00
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IONS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IONS?
Click hereIONS filed a 10-Q (SEC filing). Ionis Pharmaceuticals filed its quarterly 10-Q report for the period ended September 30, 2026, reporting cash and short-term investments of approximately $1.88 billion and total assets of $2.91 billion.
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
IONS closed at $39.42 before the filing and $31.00 on Nov 9, 2026 (-21.36%).
Get alerts when IONS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days